Jin focuses on advising issuers and investment banks on capital market transactions, such as initial public offerings and follow-on offerings. In addition, Jin represents US-listed corporate clients in regulatory compliance matters.
Cooley advised Breton Technology, an electric-powered engineering machinery provider based in China, on its HK$234 million global initial public offering (IPO).
Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).
BrainAurora Medical Technology – HK$583 Million IPO
January 8, 2025
Cooley advised the sponsors and underwriters of BrainAurora Medical Technology, a provider of medical diagnostics and digital therapies, in connection with the company’s HK$583 million initial public offering.
Cooley advised the underwriters for Fenbi, an internet-born test preparation company, on its proposed listing of shares on the Main Board of the Stock Exchange of Hong Kong Limited. Partners Ethan Jin, Michael Yu and Will Cai led the Cooley team.
